If you had a low libido for longer than six months and it's distressing you, you may have hypoactive sexual desire disorder. Find out everything you need to know.
reviews
reviews
A woman’s libido can fluctuate for a number of reasons, from high levels of stress to age-related hormonal changes.
The decrease in sex drive only becomes a problem when it becomes worrisome for you or your partner.
Hypoactive Sexual Desire Disorder is a condition where women lack sexual desire for longer than six months and it causes distress.
Some of the causes HSDD include imbalance of chemicals, side effects of medication, and psychological conditions.
Different treatment options for HSDD include therapy, medication, and Kegel exercises.
It might be that the drop in sexual desire has developed into hypoactive sexual desire disorder (HSDD). HSDD is one of the most common sexual dysfunctions in women and is treatable.
We will examine the causes, symptoms, and treatments for hypoactive sexual desire disorder so you can regain control of your sex life.
One study reported that nearly 27% of premenopausal women and 52% of menopausal women experience low desire and HSDD.
Hypoactive sexual desire disorder (HSDD) is medically defined as the lack of sexual thoughts or fantasies and a lack of desire for sexual activity, which causes distress or problems in the relationship.
Pro Tip: When it comes to relationships, communication is key, but sex can be a tricky subject. Find how to talk to your partner about sex from the professionals at Promescent.
The clinical level of distress is a key part of the HSDD diagnosis. It can involve feelings of grief, incompetence, loss, sadness, and frustration.
For a hypoactive sexual desire disorder diagnosis, the sexual dysfunction can't be attributed to another factor such as medication or physical or mental issues. And the lack of sexual thoughts or wants must last six months or longer to be considered HSDD.
The causes of hypoactive sexual desire disorder may have physical or psychological reasons, and in some cases, both.
It’s important to take the time to speak with your personal physician if you suspect you’re suffering from HSDD.
Together you can develop a plan of treatment to relieve the symptoms of hypoactive sexual desire disorder to regain control of your sexual health. Here are some potential treatment options that might be recommended:
Cognitive-behavioral therapy (CBT) is proven to treat mental health conditions, including depression, anxiety, and past trauma.
Some women benefit from CBT by learning how to deal with negative thoughts regarding sex.
Couples dealing with sexual dysfunction find that couples therapy provides ways to address their issues and regain intimacy and sexual desire.
Women with HSDD benefit from seeing a professional that focuses on sex therapy. A sex therapist addresses the specific dysfunction and can aid in assigning foreplay and sexual techniques so that you can have more satisfying sex.
In 2015, the FDA approved the medication flibanserin (Addyi) to treat hypoactive sexual desire disorder in premenopausal women.
Flibanserin is a non hormonal medication taken daily that helps increase sexual desire and sexual satisfaction.
Some doctors may prescribe other medication off-label as an HSDD treatment.
Over-the-counter libido-boosting supplements are available that may address some symptoms of HSDD.
Pro Tip: Promescent makes a safe and effective libido support supplement specifically designed for women.
Kegel exercises can help increase blood flow to the genital region for better sensation and sexual function.
Your healthcare provider will direct you on how to find the correct muscle group and the best way to squeeze and relax the Kegel muscle.
Studies suggest that three sets of 10 to 15 Kegel exercises a day can strengthen the pelvic floor and improve overall sexual health.
Making simple lifestyle changes can improve overall health, addressing the possible causes of hypoactive sexual desire disorder.
Your healthcare provider may run blood tests to diagnose hormonal imbalances and prescribe a hormone treatment.
A doctor may prescribe low-dose testosterone to address sexual dysfunction.
Hypoactive Sexual Desire Disorder (HSDD) is a common sexual dysfunction in women that is treatable. The symptoms include extreme distress concerning the lack of sexual thoughts, fantasies, and desires.
The sexual dysfunction can be cause by a number of issues such as imbalance of chemicals, side effects of medication and poor sleep quality.
Once a healthcare professional diagnoses HSDD, the treatment plan can include talk therapy, medication, lifestyle changes, or hormone therapy.
With help from your doctor and cooperation from your partner, you can treat HSDD and return to having a pleasurable sex life.
Our team has over a decade of experience in the sexual wellness field and are experts in sexual dysfunctions, like premature ejaculation. We help couples and individuals better understand treatment options available for different types of sexual needs and educate the public on all things related to intimacy. All of our authored content is medically reviewed for accuracy and reliability.
Absorption Pharmaceuticals LLC (Promescent) has strict informational citing guidelines and relies on peer-reviewed studies, academic or research institutions, medical associations, and medical experts. We attempt to use primary sources and refrain from using tertiary references and only citing trustworthy sources. Each article is reviewed, written, and updated by Medical Professionals or authoritative Experts in a specific, related field of practice. You can find out more about how we ensure our content is accurate and current by reading our editorial policy.
Nappi RE, Martini E, Terreno E, et al. Management of hypoactive sexual desire disorder in women: current and emerging therapies. Int J Womens Health. 2010;2:167-175. Published 2010 Aug 9. doi:10.2147/ijwh.s7578. Accessed on Sep, 27, 2023.
West SL, D'Aloisio AA, Agans RP, Kalsbeek WD, Borisov NN, Thorp JM. Prevalence of low sexual desire and hypoactive sexual desire disorder in a nationally representative sample of US women. Arch Intern Med. 2008 Jul 14;168(13):1441-9. doi: 10.1001/archinte.168.13.1441. PMID: 18625925. Accessed on Sep, 27, 2023.
Pettigrew JA, Novick AM. Hypoactive Sexual Desire Disorder in Women: Physiology, Assessment, Diagnosis, and Treatment. J Midwifery Womens Health. 2021;66(6):740-748. doi:10.1111/jmwh.13283. Accessed on Sep, 27, 2023.
Croft HA. Understanding the Role of Serotonin in Female Hypoactive Sexual Desire Disorder and Treatment Options. J Sex Med. 2017 Dec;14(12):1575-1584. doi: 10.1016/j.jsxm.2017.10.068. PMID: 29198512. Accessed on Sep, 27, 2023.
Lorenz T, Rullo J, Faubion S. Antidepressant-Induced Female Sexual Dysfunction. Mayo Clin Proc. 2016;91(9):1280-1286. doi:10.1016/j.mayocp.2016.04.033. Accessed on Sep, 27, 2023.
Christensen B. Inflammatory bowel disease and sexual dysfunction. Gastroenterol Hepatol (N Y). 2014;10(1):53-55. Accessed on Sep, 27, 2023.
Christensen B. Inflammatory bowel disease and sexual dysfunction. Gastroenterol Hepatol (N Y). 2014;10(1):53-55. Accessed on Sep, 27, 2023.
Kalmbach DA, Arnedt JT, Pillai V, Ciesla JA. The impact of sleep on female sexual response and behavior: a pilot study. J Sex Med. 2015 May;12(5):1221-32. doi: 10.1111/jsm.12858. Epub 2015 Mar 16. PMID: 25772315. Accessed on Sep, 27, 2023.
AlAwlaqi A, Amor H, Hammadeh ME. Role of hormones in hypoactive sexual desire disorder and current treatment. J Turk Ger Gynecol Assoc. 2017;18(4):210-218. doi:10.4274/jtgga.2017.0071. Accessed on Sep, 27, 2023.
Mestre-Bach G, Blycker GR, Potenza MN. Behavioral Therapies for Treating Female Sexual Dysfunctions: A State-of-the-Art Review. J Clin Med. 2022;11(10):2794. Published 2022 May 16. doi:10.3390/jcm11102794. Accessed on Sep, 27, 2023.
Pereira VM, Arias-Carrión O, Machado S, Nardi AE, Silva AC. Sex therapy for female sexual dysfunction. Int Arch Med. 2013;6(1):37. Published 2013 Sep 26. doi:10.1186/1755-7682-6-37. Accessed on Sep, 27, 2023.
Pierrelus C, Carlson K. Flibanserin. [Updated 2023 Mar 8]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2023 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK589649/#. Accessed on Sep, 27, 2023.
Razali NA, Sidi H, Choy CL, Roos NAC, Baharudin A, Das S. The Role of Bupropion in the Treatment of Women with Sexual Desire Disorder: A Systematic Review and Meta-Analysis. Curr Neuropharmacol. 2022;20(10):1941-1955. doi:10.2174/1570159X20666220222145735. Accessed on Sep, 27, 2023.
Landén M, Eriksson E, Agren H, Fahlén T. Effect of buspirone on sexual dysfunction in depressed patients treated with selective serotonin reuptake inhibitors. J Clin Psychopharmacol. 1999 Jun;19(3):268-71. doi: 10.1097/00004714-199906000-00012. PMID: 10350034. Accessed on Sep, 27, 2023.
Basson R. Testosterone therapy for reduced libido in women. Ther Adv Endocrinol Metab. 2010;1(4):155-164. doi:10.1177/2042018810379588. Accessed on Sep, 27, 2023.
Edinoff AN, Sanders NM, Lewis KB, et al. Bremelanotide for Treatment of Female Hypoactive Sexual Desire. Neurol Int. 2022;14(1):75-88. Published 2022 Jan 4. doi:10.3390/neurolint14010006. Accessed on Sep, 27, 2023.
Huang YC, Chang KV. Kegel Exercises. [Updated 2023 May 1]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2023 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK555898/. Accessed on Sep, 27, 2023.
Kanter G, Rogers RG, Pauls RN, Kammerer-Doak D, Thakar R. A strong pelvic floor is associated with higher rates of sexual activity in women with pelvic floor disorders. Int Urogynecol J. 2015;26(7):991-996. doi:10.1007/s00192-014-2583-7. Accessed on Sep, 27, 2023.
Kling JM, Manson JE, Naughton MJ, et al. Association of sleep disturbance and sexual function in postmenopausal women. Menopause. 2017;24(6):604-612. doi:10.1097/GME.0000000000000824. Accessed on Sep, 27, 2023.
Dhikav V, Karmarkar G, Gupta R, Verma M, Gupta R, Gupta S, Anand KS. Yoga in female sexual functions. J Sex Med. 2010 Feb;7(2 Pt 2):964-70. doi: 10.1111/j.1743-6109.2009.01580.x. Epub 2009 Nov 12. PMID: 19912493. Accessed on Sep, 27, 2023.
Costa RM, Peres L. Smoking is unrelated to female sexual function. Subst Use Misuse. 2015 Jan;50(2):189-94. doi: 10.3109/10826084.2014.962054. Epub 2014 Oct 7. PMID: 25290661. Accessed on Sep, 27, 2023.
reviews
Your Cart Is Empty